Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma

SUPPLEMENTARY FIGURES AND TABLES Supplementary
: Effect of IL-1 blockade on growth of erlotinib-resistant CAL 27 xenografts. Erlotinib-resistant CAL 27 tumor bearing male A. and female B. mice were treated with reagent grade water (Con), erlotinib (Erl), anakinra (Ana) or erlotinib+anakinra (Ana+Erl) for 2 weeks. Tumor volumes were plotted against days since treatment initiation. Tumor growth graphs were interrupted at the time point where the mice (in any of the treatment groups) began to reach euthanasia criteria due to tumor size or ulcerating tumors. N = 5-6 mice per treatment group. Error bars represent ± SEM. 
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